Antibodies

25 Apr 2018 ADC Therapeutics Announces the Termination of its ADCT-502 Program Targeting HER2 Expressing Solid Tumors
25 Apr 2018 AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis
24 Apr 2018 AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
24 Apr 2018 European Medicines Agency Validates Type II Variation for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and Platinum Chemotherapy as First-Line Therapy in Metastatic Nonsquamous NSCLC, Based on Phase 3 KEYNOTE-189 Trial
24 Apr 2018 Connect Biopharmaceuticals Advances CBP-201, a Novel Monoclonal Antibody Against IL-4Rα, Into Clinical Development
24 Apr 2018 AstraZeneca reports results from the ARCTIC trial in third-line non-small cell lung cancer
23 Apr 2018 Pfizer Provides Update on Proposed Trastuzumab Biosimilar
23 Apr 2018 MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy
23 Apr 2018 Prothena Discontinues Development of NEOD001 for AL Amyloidosis
23 Apr 2018 New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis
19 Apr 2018 U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treated Patients with Small Cell Lung Cancer and Grants Priority Review
19 Apr 2018 Xencor Presents Preclinical Data on XmAb®24306, Introduces XmAb® IL15 Bispecific Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting
19 Apr 2018 OncoMed Presents Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting
18 Apr 2018 Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018
18 Apr 2018 Ultragenyx and Kyowa Kirin Announce FDA Approval of Crysvita® (burosumab-twza) for the Treatment of Children and Adults with X–Linked Hypophosphatemia (XLH)
18 Apr 2018 Zymeworks Presents Preclinical Data at the Annual Meeting of the American Association for Cancer Research
17 Apr 2018 Checkmate Pharmaceuticals Presents Clinical Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
17 Apr 2018 Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy in Cancer Immunotherapy
17 Apr 2018 FDA Provides Full Approval to Praxbind, Specific Reversal Agent for Pradaxa
17 Apr 2018 Alligator Bioscience Presents ATOR-1015 Preclinical Data at the AACR Annual Meeting 2018 Confirming Localized Tumor Activation
17 Apr 2018 Celldex's METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
17 Apr 2018 AntoXa Corporation granted Defence R&D Canada license for novel, plant-made anti-ricin antibody
17 Apr 2018 JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers
17 Apr 2018 Five Prime Presents on Novel B7-H4 Therapeutic Antibody at the 2018 AACR Annual Meeting
17 Apr 2018 Harpoon Therapeutics Launches Immuno-Oncology Pipeline With Compelling Data From Lead Programs at the 2018 American Association for Cancer Research (AACR) Annual Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top